Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography

Conditions:   Coronary Artery Disease;   ECG Abnormalities From Contrast Agents Interventions:   Drug: Iodixanol;   Drug: Iohexol Sponsor:   Minneapolis Heart Institute Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Iohexol | Omnipaque | Research